ARGX

Q: What is the price of argenx (ARGX) today?

A cotação de argenx (ARGX) hoje está em $ 776.26, com uma variação de The stock began the year trading around $ 840.95 and is currently priced at $ 776.26. negociando na casa dos $ 840.95 e hoje está em $ 776.26. Acompanhe o and track broader market trends directly on the platform.

Q: When does argenx (ARGX) pay dividends?

argenx (ARGX) did not pay dividends over the past year.

Q: Is argenx (ARGX) a good investment?

Atualmente, argenx (ARGX) está cotada a $ 776.26, com um P/L de 33.28, This represents a 262% premium compared to its historical average P/E. uma variação de 37.24 em sua cotação e distribuiu $ 0.00 em dividendos, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was 37.24%.Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

argenx SE

Price

$ 776.26

return (12m)

37.24%

p/e

33.28

p/bv

0.00

DIVIDEND YIELD

0.00%

ARGX price

ARGX

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

15 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment ARGX

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-8.57%

3 months

-7.98%

1 year

37.24%

2 years

114.69%

5 years

188.80%

10 years

0.00%

Fundamentals ARGX

review the fundamentals of argenx shares

P/E

33.28

Sector: -9.59 Industry: -9.59

P/S (PSR)

10.63

Sector: -138.14 Industry: -138.14

P/BV

0.00

Sector: 1.99 Industry: 1.99

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

0.00%

Sector: -31.16% Industry: -31.16%

ROE

0.00%

Sector: -31.19% Industry: -31.19%

ROIC

38.17%

Sector: -2,596.17% Industry: -2,596.17%

NET MARGIN

31.94%

Sector: -39.99% Industry: -39.99%

GROSS MARGIN

89.47%

Sector: 37.30% Industry: 37.30%

OPERATING MARGIN

28.09%

Sector: -39.14% Industry: -39.14%

EV/EBITDA

32.89

Sector: -10.69 Industry: -10.69

EV/EBIT

32.89

Sector: -10.50 Industry: -10.50

PRICE-TO-ASSETS

Sector: 1.43 Industry: 1.43

BVPS

Sector: 1.96 Industry: 1.96

EPS

24.02

Sector: -1.07 Industry: -1.07

EQUITY-TO-ASSETS RATIO

Sector: 0.44 Industry: 0.44

LIABILITIES / ASSETS

Sector: 0.39 Industry: 0.39

CAGR REVENUE 5 YEARS

56.45%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

0.00%

Sector: - Industry: -

Fundamentals ARGX

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
JNJ	103.71	6.69	6.45%	2.31%	$ 542.92 B	21.76%
PFE	52.78	1.57	2.97%	6.90%	$ 141.82 B	18.60%
ABBV	535.81	-56.32	-10.51%	3.20%	$ 372.39 B	4.63%
NVO	26.47	6.33	23.91%	4.17%	$ 198.78 B	50.15%
AZN	91.32	5.94	6.50%	1.76%	$ 281.27 B	20.15%
GILD	79.63	6.87	8.63%	2.46%	$ 160.94 B	29.04%
BMY	43.39	5.78	13.32%	4.39%	$ 116.17 B	23.30%
ZTS	52.11	9.69	18.59%	2.74%	$ 31.32 B	26.57%
REGN	99.86	2.31	2.31%	0.51%	$ 72.62 B	20.17%
HALO	52.78	36.06	68.32%	0.00%	$ 7.92 B	39.83%
AMGN	96.87	19.17	19.79%	2.96%	$ 176.21 B	21.11%
MCK	55.17	-111.26	-201.68%	0.42%	$ 92.79 B	1.75%
HRMY	53.72	1.92	3.57%	0.00%	$ 1.75 B	15.08%
VRTX	107.61	5.73	5.33%	0.00%	$ 110.99 B	34.53%
CAH	114.64	-17.12	-14.93%	1.05%	$ 45.74 B	0.65%
ADMA	43.06	5.00	11.61%	0.00%	$ 1.95 B	39.59%
BIIB	88.77	1.52	1.71%	0.00%	$ 28.36 B	12.89%

Stock vs Indice Comparison Tool

If you had invested

years ago

2 years

5 years

10 years

ago, you would now have *

ago, you would now have:

*The value considers the reinvestment of dividends.

ARGX Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT argenx

argenx SE

Average Investor10 user rating

4.0 (12 people)

United States

18 years

Founded: 2008

2017

Time since IPO - 9 years

336

Employees

argenx SE (United States) is listed on the Nasdaq and has a market capitalization of $49.56 Billions, with shareholders equity totaling $-.

The company employs approximately 336 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, argenx SE reported $4.66 Billions in revenue, generating net income of $1.49 Billion.

Key financial metrics include a P/E ratio of 33.28, a price-to-book (P/B) ratio of 0.00, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker ARGX.

Market cap

$ 49.56 Billions

Net worth

$ -

Assets

$ -

Total Shares Outstanding

62.00 Millions

62,000,000

Average Daily Trading Volume

$ 332.87 Thousand

$ 332,870.40

Sector

Health Care

Industry

Biotechnology

ARGX

ARGX revenue and profits

Financial Results ARGX

DRAG THE FRAME TO SEE MORE DATA

ARGX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

BFRA - Biofrontera

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$ 775.97 7,36% (12M)

P/E

55.17

0.42%

ROE

-201.68%

P/BV

-111.26

CAH - Cardinal Health

$ 199.77 31,67% (12M)

P/E

114.64

1.05%

ROE

-14.93%

P/BV

-17.12

JNJ - Johnson & Johnson

$ 228.92 55,22% (12M)

P/E

103.71

2.31%

ROE

6.45%

P/BV

6.69

MRK - Merck & Co.

$ 112.56 51,01% (12M)

P/E

-64.94

2.98%

ROE

-9.23%

P/BV

5.99

AZN - AstraZeneca

$ 183.92 33,83% (12M)

P/E

91.32

1.76%

ROE

6.50%

P/BV

5.94

ABBV - AbbVie

$ 209.41 16,34% (12M)

P/E

535.81

3.20%

ROE

-10.51%

P/BV

-56.32

NVO - Novo Nordisk

$ 44.28 --30,73% (12M)

P/E

26.47

4.17%

ROE

23.91%

P/BV

6.33

BFRA - Biofrontera

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$ 775.97 7,36% (12 M)

P/L

55.17

0.42%

ROE

-201.68%

P/VP

-111.26

CAH - Cardinal Health

$ 199.77 31,67% (12 M)

P/L

114.64

1.05%

ROE

-14.93%

P/VP

-17.12

JNJ - Johnson & Johnson

$ 228.92 55,22% (12 M)

P/L

103.71

2.31%

ROE

6.45%

P/VP

6.69

MRK - Merck & Co.

$ 112.56 51,01% (12 M)

P/L

-64.94

2.98%

ROE

-9.23%

P/VP

5.99

AZN - AstraZeneca

$ 183.92 33,83% (12 M)

P/L

91.32

1.76%

ROE

6.50%

P/VP

5.94

ABBV - AbbVie

$ 209.41 16,34% (12 M)

P/L

535.81

3.20%

ROE

-10.51%

P/VP

-56.32

NVO - Novo Nordisk

$ 44.28 --30,73% (12 M)

P/L

26.47

4.17%

ROE

23.91%

P/VP

6.33

Frequently Asked Questions

What is the price of argenx (ARGX) today?

A cotação de argenx (ARGX) hoje está em $ 776.26, com uma variação de The stock began the year trading around $ 840.95 and is currently priced at $ 776.26. negociando na casa dos $ 840.95 e hoje está em $ 776.26. Acompanhe o and track broader market trends directly on the platform.

When does argenx (ARGX) pay dividends?

argenx (ARGX) did not pay dividends over the past year.

Is argenx (ARGX) a good investment?

Atualmente, argenx (ARGX) está cotada a $ 776.26, com um P/L de 33.28, This represents a 262% premium compared to its historical average P/E. uma variação de 37.24 em sua cotação e distribuiu $ 0.00 em dividendos, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was 37.24%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy argenx (ARGX) stock?

You can buy argenx (ARGX) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol ARGX and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of argenx (ARGX) yield today?

Over the past month, argenx (ARGX) has returned -8.57% — 37.24% over the past year, and 188.80% over the past five years, including price appreciation and dividends.

Nos últimos 12 meses, a empresa pagou um total de $ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de argenx (ARGX) hoje, o investimento total seria de $ 77,626.00, com base na cotação atual de $ 776.26.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: $ 106,533.92
Em 5 anos: $ 224,183.89
Em 10 anos: $ 77,626.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

ARGX

argenx SE

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment ARGX

review the fundamentals of argenx shares

P/E

P/S (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

EV/EBITDA

EV/EBIT

PRICE-TO-ASSETS

BVPS

EPS

EQUITY-TO-ASSETS RATIO

LIABILITIES / ASSETS

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

current DY: 0.00%

5-year average DY: 0.00%

ABOUT argenx

argenx SE

United States

18 years

2017

336

PROFIT X PRICE ARGX

Financial Results ARGX

ARGX cash flow

Asset, Revenue and Profit Growth - ARGX

ARGX balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

AZN - AstraZeneca

ABBV - AbbVie

NVO - Novo Nordisk

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

AZN - AstraZeneca

ABBV - AbbVie

NVO - Novo Nordisk

Frequently Asked Questions